Cancer therapy development has advanced to researching targeted immunotherapies and are moving into gene-specific therapies.  Some companies, however, are focusing on reviving cytotoxic therapies that were too toxic for patients when administered generally. These companies are developing targeted transportation mechanisms to deliver cytotoxic release at tumor cells while minimizing overall toxicity to patients. Bill Newell, Chief […]

CEO Dr Raza Bokhari says the transaction symbolizes FSD Pharma’s vision of acquiring a platform company to advance R&D in FDA-approved applications of ‘synthetic cannabinoids’ FSD Pharma Inc (CSE:HUGE) (OTCMKTS:FSDDF) announced Tuesday that it has signed an agreement to acquire US-based specialty research and development pharma company Prismic Pharmaceuticals. The Candian company which grows medical-grade […]

The advent of highly active antiretroviral therapy (HAART) in the 1990s revolutionized HIV/AIDS treatment. But while it dramatically improves survival, some patients can develop troublesome side effects or even resistance to the potent pills. So, the search for an alternative has continued. Enter UB-421. An antibody that is infused into the bloodstream, this new compound […]